SCOTTSDALE, Ariz.--(BUSINESS WIRE)--eFoodSafety.com, Inc. (OTCBB: EFSF, www.efoodsafety.com) applauds the European Commission’s marketing authorization in the European Union of GlaxoSmithKline’s (“GSK”) H5N1 pre-pandemic bird flu vaccine Prepandrix™. eFoodSafety, which is also dedicated to developing solutions aimed at combating the virulent H5N1 strain of bird flu, commends the European Commission for raising global awareness of the influenza pandemic and allowing for the advancement of technologies designed to address potential human threats relating to this deadly virus. The company’s proprietary product, Citroxin™, an environmentally safe sporicidal product formulated entirely of food-grade components, has shown 68% efficacy in eradicating the H5N1 strain of bird flu in chick embryos.
